RaySearch publishes preliminary Q2 2026 results
Net sales expected at SEK 272M, operating profit SEK 28M, order intake SEK 296M, and free cash flow SEK 50M.
See the latest news and media coverage for RaySearch. We track all announcements, press releases, and industry mentions in real time, all in one place.
Radiation therapy and oncology software provider
raysearchlabs.comLast updated
In short: RaySearch achieved record 2025 revenue, entered new markets in Vietnam and China, and expanded its oncology software with AI innovations.
Net sales expected at SEK 272M, operating profit SEK 28M, order intake SEK 296M, and free cash flow SEK 50M.
The oncology information system adds a new workflow timeline, encrypted DICOM, and standardized device interfaces.
The board resolved to buy back up to SEK 158.4 million of Class B shares to adjust capital structure and increase shareholder value.
The pioneer in proton therapy will strengthen RaySearch's strategic development in particle therapy.
Earnings call RaySearch Laboratories delivered record Q3 2025 net sales of SEK 332 million, up 13% YoY, and a 44% increase in operating profit to...
Detailed price information for Raysearch Labs Ab Ord (RSLBF) from The Globe and Mail including charting and trades.
Detailed price information for Raysearch Labs Ab Ord (RSLBF) from The Globe and Mail including charting and trades.
RaySearch Laboratories AB (publ) is pleased to announce that Iridium Network in Belgium has successfully completed its first online adaptive radiation treatment using RayStation®* and...
Track RaySearch and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.